Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

待确认 10 由 nana 发布于 2026/1/27 14:08:10

DOI:10.1038/s41591-025-03899-x
作者：Xiaobing Wang, Yi Zhang, Huimin Wang, Xin Wu, Chao He, Suxian Lin, Kun Pang, Yang Li, Yue Chen, Xiaojing Tang, Xin Liu, Jiazheng Wang, Songy
文献类型：期刊论文
补充材料：只需要正文

Nature

Abstract：Commercial autologous anti-CD19 chimeric antigen receptor-T cell therapies are effective in B cell malignancies and autoimmune diseases but are limited by personalized manufacturing, high co

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

3小时前

biofresh

daaa5904fb4911f0b46d34735aa3bc31.pdf

3小时前

Book学术机器人

2026/1/27 14:08:10 未找到该文献，机器人已退出，请等待人工下载

2026/1/27 14:08:10 Book学术AI机器人收到请求，开始寻找文献

2026/1/27 14:08:10 已向机器人发送请求

3小时前

nana 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Institute of Electrical and Electronics Engineers (IEEE)Sentences Based Adversarial Attack on AI-Generated Text Detectors